Pelican Therapeutics, Inc. — Form D
Pelican Therapeutics, Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-18. The offering totals $1.0M, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-08-18
- Form: D
- Accession: 0001553350-15-000887
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $250K
- Remaining: $750K
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2015-08-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-246033
Issuer
- Name: Pelican Therapeutics, Inc.
- CIK: 0001610154
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3112 WINDSOR ROAD, AUSTIN, TX, 78703
- Phone: 917-892-9996
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Josiah Hornblower | Director | Austin, TX |
| Rahul Jasuja | Director | Boca Raton, FL |
| Taylor Schreiber | Director | Austin, TX |
| Edward B Smith | Director | New York, NY |
| Jeffrey Wolf | Director | Rockville, MD |
| Josiah Hornblower | Executive Officer | Austin, TX |
| Nico M Pronk | Director | WESTON, FL |
| Shawn M Titcomb | Director | WESTON, FL |
| Jules Musing | Director | Boca Raton, FL |
| Taylor H Schreiber | Director | Boca Raton, FL |
| Josiah H Hornblower | Director | Boca Raton, FL |
| Josiah H Hornblower | Executive Officer | Boca Raton, FL |
Other filings by this issuer (1)
More